CSI Market
Sign In | Register

Timber Pharmaceuticals Inc (TMBR) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access TMBR Annual Cash Flow →
Reviewing cash flow data across recent quarters allows users to assess how Timber Pharmaceuticals Inc adapts its cash strategy across cycles.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2023)
6 Months 		(Mar 31 2023) (Dec 31 2022) (Sep 30 2022) (Jun 30 2022)
Operating Activities
Income-8.12
Depreciation & amortization0.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.27
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Operating Income Loss-
Interest Expense-
Increase Decrease Fair Value Of Warrant And Stock Liability-
Research And Development License Acquired-
Non Cash Contribution From Tardimed-
Amortization Of Loan Discount-
Finance Lease Right Of Use Asset Amortization0.17
Increase Decrease In Interest Payable On Biopharmx Loan-
Increase Decrease In Interest Payable On Bridge Notes-
Increase Decrease In Other Assets Current-
Debt Instrument Increase Decrease Forgiveness-
Non Cash Interest Expenses On Reclassification Of Redeemable Preferred Stock-
Increase Decrease In Operating Lease Liability-0.17
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Other Receivables0.00
Increase (Decrease) in Accounts Payable, Trade0.28
Increase (Decrease) in Accrued Liabilities0.41
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.37
Other Working Capital0.07
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.16
Discontinued operations0.00
Net Cash flow from Operating Activities-6.56
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Loan To Biopharamx-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-9.08
Repurchase Of Common Stock Value-
Net Proceeds From Sale Of Common Stock And Warrants-
Proceeds From Issuance Of Convertible Preferred Stock And Warrants-
Purchases Of Property And Equipment Through Capital Leases-
Noncash Conversion Of Preferred Stock To Common Stock-
Property And Equipment Acquired Through Finance Lease-
Debt Conversion Converted Instrument Amount-
Fair Value Of Common Stock Liability Reclassed To Accrued Expenses And Other-
Proceeds From Bridge Notes Payable-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents9.08
Proceeds From Ppp Loans-
Proceeds From Issuance Of Common Stock Preferred Stock And Warrants-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-6.56
Total Cash Flow-6.56
4 historic quarters locked

Sign in to unlock the full Timber Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About Timber Pharmaceuticals Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001437749-23-024294

Figures are derived from filed reports and may be restated. Historical data is subject to revision.